Profile data is unavailable for this security.
About the company
Humana Inc. is a healthcare company. It operates through two segments: Insurance and CenterWell. The Insurance segment consists of Medicare benefits, marketed to individuals or directly through group Medicare accounts. It also includes its contract with the Centers for Medicare and Medicaid Services (CMS) to administer the Limited Income Newly Eligible Transition (LI-NET), a prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits. It also includes products consisting of employer group commercial fully insured medical and specialty health insurance benefits. The CenterWell segment includes pharmacy solutions, primary care, and home solutions operations. It also includes its strategic partnerships with Welsh, Carson, Anderson & Stowe (WCAS) to develop and operate senior-focused, payor-agnostic, primary care centers, as well as a minority ownership interest in Gentiva Hospice operations.
- Revenue in USD (TTM)115.01bn
- Net income in USD1.36bn
- Incorporated1964
- Employees67.60k
- LocationHumana Inc500 W Main StLOUISVILLE 40202United StatesUSA
- Phone+1 (502) 580-1000
- Fax+1 (302) 655-5049
- Websitehttps://www.humana.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chemed Corp | 2.38bn | 301.73m | 8.28bn | 15.09k | 27.95 | 6.68 | 22.73 | 3.48 | 19.78 | 19.78 | 155.82 | 82.78 | 1.43 | 136.49 | 13.04 | 157,566.50 | 18.11 | 19.53 | 21.79 | 24.64 | 35.66 | 34.60 | 12.69 | 12.60 | 1.81 | -- | 0.00 | 8.15 | 6.06 | 4.90 | 9.17 | 5.80 | 1.46 | 6.10 |
| Ensign Group Inc | 4.11bn | 239.98m | 8.29bn | 35.30k | 35.01 | 4.74 | 25.79 | 2.02 | 4.13 | 4.13 | 70.86 | 30.50 | 0.9433 | -- | 8.01 | 116,391.30 | 5.52 | 6.45 | 6.63 | 7.88 | 21.19 | 22.32 | 5.85 | 6.48 | -- | -- | 0.0773 | 6.56 | 23.27 | 16.28 | -6.80 | 28.62 | 4.40 | 5.02 |
| Encompass Health Corp | 5.22bn | 431.20m | 9.97bn | 22.36k | 23.41 | 5.09 | 11.66 | 1.91 | 4.23 | 4.11 | 51.10 | 19.45 | 0.8396 | -- | 9.38 | 233,270.70 | 9.07 | 6.37 | 11.87 | 7.94 | 95.49 | 95.58 | 10.80 | 9.16 | -- | 6.14 | 0.486 | 30.78 | 10.41 | 2.34 | 41.31 | 4.49 | 16.60 | -10.42 |
| Universal Health Services, Inc. | 15.42bn | 1.03bn | 13.04bn | 73.35k | 13.14 | 1.97 | 8.01 | 0.846 | 15.03 | 15.03 | 225.85 | 100.14 | 1.09 | -- | 6.93 | 210,194.40 | 7.41 | 6.44 | 8.68 | 7.63 | -- | -- | 6.78 | 6.55 | 1.28 | 7.70 | 0.4105 | 6.06 | 6.59 | 5.80 | 6.32 | -1.47 | 1.17 | 14.87 |
| Davita Inc | 12.67bn | 827.68m | 13.23bn | 70.00k | 17.40 | 34.48 | 7.05 | 1.04 | 9.28 | 9.28 | 141.50 | 4.68 | 0.7357 | 71.34 | 5.90 | 180,951.60 | 6.58 | 5.62 | 8.88 | 7.45 | 32.80 | 30.70 | 8.94 | 8.33 | 1.33 | 4.77 | 0.8115 | -- | 4.57 | 1.26 | 26.44 | 2.33 | -10.47 | -- |
| Tenet Healthcare Corp | 20.97bn | 3.13bn | 14.44bn | 78.14k | 4.86 | 3.77 | 3.02 | 0.6885 | 31.26 | 31.26 | 209.81 | 40.32 | 0.7364 | 9.49 | 7.15 | 268,376.30 | 13.86 | 3.61 | 20.23 | 5.09 | 82.61 | 82.97 | 18.83 | 4.95 | 1.52 | 5.37 | 0.6145 | 0.00 | 7.17 | 2.33 | 49.02 | 41.42 | 4.01 | -- |
| Molina Healthcare Inc | 39.20bn | 1.14bn | 16.85bn | 18.00k | 14.95 | 3.52 | 12.72 | 0.4299 | 19.70 | 19.70 | 674.97 | 83.68 | 2.56 | -- | 13.71 | 2,177,722.00 | 7.47 | 7.62 | 16.58 | 16.80 | 16.12 | 15.99 | 2.92 | 3.04 | -- | 14.83 | 0.3465 | 0.00 | 6.56 | 12.52 | 37.75 | 9.06 | 22.87 | -- |
| Quest Diagnostics Inc | 9.54bn | 838.00m | 18.01bn | 40.00k | 21.66 | 2.65 | 13.49 | 1.89 | 7.45 | 7.45 | 84.79 | 60.79 | 0.645 | 34.77 | 7.18 | 238,475.00 | 5.87 | 9.28 | 6.77 | 10.81 | 32.94 | 36.64 | 9.10 | 12.97 | 1.17 | 8.87 | 0.4746 | 25.07 | -6.38 | 4.20 | -9.77 | 3.40 | 1.27 | 7.43 |
| Labcorp Holdings Inc | 12.71bn | 435.50m | 19.89bn | 67.00k | 46.09 | 2.44 | 18.84 | 1.56 | 5.16 | 5.16 | 150.40 | 97.61 | 0.7162 | 19.41 | 5.93 | 189,743.30 | 2.46 | 6.27 | 3.00 | 7.37 | 27.92 | 32.33 | 3.44 | 9.51 | 1.30 | 5.59 | 0.455 | -- | 2.51 | 1.42 | -62.16 | -16.40 | 3.62 | -- |
| Natera Inc | 1.53bn | -214.69m | 20.76bn | 3.28k | -- | 23.72 | -- | 13.55 | -1.77 | -1.77 | 12.59 | 7.08 | 1.01 | 14.29 | 5.45 | 466,774.80 | -14.14 | -36.17 | -17.55 | -46.60 | 57.66 | 45.88 | -14.01 | -56.15 | 4.23 | -- | 0.2947 | -- | 31.99 | 33.26 | 20.63 | -- | 58.81 | -- |
| Centene Corp | 161.73bn | 3.07bn | 29.84bn | 67.70k | 10.25 | 1.10 | 6.95 | 0.1845 | 5.77 | 5.77 | 303.72 | 53.53 | 1.94 | -- | 9.57 | 2,388,863.00 | 3.66 | 2.58 | 6.39 | 3.99 | 10.37 | 11.59 | 1.89 | 1.37 | -- | 4.06 | 0.3911 | 0.00 | 6.54 | 20.70 | 124.79 | 24.59 | 3.43 | -- |
| Humana Inc | 115.01bn | 1.36bn | 35.40bn | 67.60k | 26.03 | 2.02 | 14.72 | 0.3078 | 11.29 | 11.29 | 948.23 | 145.88 | 2.17 | -- | -- | 1,701,331.00 | 2.72 | 7.57 | -- | -- | -- | -- | 1.25 | 3.35 | -- | 5.38 | 0.4249 | 12.54 | 14.54 | 13.33 | -11.30 | 7.65 | 10.41 | 13.25 |
| Holder | Shares | % Held |
|---|---|---|
| The Vanguard Group, Inc.as of 30 Sep 2024 | 10.54m | 8.76% |
| BlackRock Fund Advisorsas of 30 Sep 2024 | 6.67m | 5.54% |
| SSgA Funds Management, Inc.as of 30 Sep 2024 | 5.36m | 4.45% |
| Dodge & Coxas of 30 Sep 2024 | 4.93m | 4.10% |
| Wellington Management Co. LLPas of 30 Sep 2024 | 4.40m | 3.66% |
| Eagle Capital Management LLCas of 30 Sep 2024 | 3.25m | 2.70% |
| Geode Capital Management LLCas of 30 Sep 2024 | 2.82m | 2.34% |
| Pzena Investment Management LLCas of 30 Sep 2024 | 2.51m | 2.08% |
| Davis Selected Advisers LPas of 30 Sep 2024 | 2.31m | 1.92% |
| T. Rowe Price Associates, Inc. (IM)as of 30 Sep 2024 | 2.07m | 1.72% |
